Cingulate Inc. Employee Directory
Pharmaceutical ManufacturingKansas, United States11-50 Employees
Cingulate Inc. is a biopharmaceutical company based in Mission, Kansas, pursuing a pipeline of next-generation medicines developed on a proprietary precision timed release drug delivery platform. The company targets conditions that require burdensome daily dosing and seeks to improve onset and duration of treatment to deliver better patient outcomes, with an initial focus on Attention Deficit/Hyperactivity Disorder. Its technology is positioned to be applied across additional therapeutic areas, notably anxiety disorders. In June 2026, the U.S. Food and Drug Administration issued a Complete Response Letter regarding the NDA for CTx-1301 (dexmethylphenidate HCl) for ADHD, marking a regulatory milestone for the company. Based in Mission, Kansas, the company operates within the pharmaceutical manufacturing sector and aims to address unmet needs by improving dosing regimens and patient outcomes through its PTR platform.